Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Tessier

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Obstetrics and Gynecology|August 1, 1997
Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertilityG N Smith, M Walker, J L Tessier, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[T4 and T8 lymphocytic populations after total hip replacement]P Seyral, G Lévy, M Jamet, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 1, 2005
Should we resurface the patella in total knee replacement? Experience with the Nex Gen prothesisJ Tabutin, F Banon, Y Catonne, et al.
NMR in Biomedicine|April 27, 2007
Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)D P Bradley, J L Tessier, D Checkley, et al.
Magnetic Resonance Imaging|July 25, 2003
Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenograftsDavid Checkley, Jean J L Tessier, Stephen R Wedge, et al.
The British Journal of Radiology|April 10, 2003
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting gliomaA Jackson, G C Jayson, K L Li, et al.
The British Journal of Radiology|February 22, 2003
Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI dataK L Li, X P Zhu, D R Checkley, et al.
Presse Medicale (Paris, France : 1983)|October 26, 1991
[Monitoring after total hip prosthesis. Value of semi-quantitative D-dimer assay]G Levy, P Y Levy, P Monin, et al.
Magnetic Resonance Imaging|November 6, 2003
Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast mediaC Pradel, N Siauve, G Bruneteau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumorsMaria Martinez-Garcia, Udai Banerji, Joan Albanell, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Obstetrics and Gynecology|August 1, 1997
Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertilityG N Smith, M Walker, J L Tessier, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[T4 and T8 lymphocytic populations after total hip replacement]P Seyral, G Lévy, M Jamet, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 1, 2005
Should we resurface the patella in total knee replacement? Experience with the Nex Gen prothesisJ Tabutin, F Banon, Y Catonne, et al.
NMR in Biomedicine|April 27, 2007
Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)D P Bradley, J L Tessier, D Checkley, et al.
Magnetic Resonance Imaging|July 25, 2003
Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenograftsDavid Checkley, Jean J L Tessier, Stephen R Wedge, et al.
The British Journal of Radiology|April 10, 2003
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting gliomaA Jackson, G C Jayson, K L Li, et al.
The British Journal of Radiology|February 22, 2003
Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI dataK L Li, X P Zhu, D R Checkley, et al.
Presse Medicale (Paris, France : 1983)|October 26, 1991
[Monitoring after total hip prosthesis. Value of semi-quantitative D-dimer assay]G Levy, P Y Levy, P Monin, et al.
Magnetic Resonance Imaging|November 6, 2003
Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast mediaC Pradel, N Siauve, G Bruneteau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumorsMaria Martinez-Garcia, Udai Banerji, Joan Albanell, et al.
Pageof 2